Cytokinetics Statistics

Total Valuation

Cytokinetics has a market cap or net worth of EUR 3.95 billion. The enterprise value is 4.07 billion.

Market Cap	3.95B
Enterprise Value	4.07B

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	119.66M
Shares Outstanding	n/a
Shares Change (YoY)	+16.37%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	119.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.13
PB Ratio	-12.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.88
EV / Sales	55.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.88

Financial Position

The company has a current ratio of 6.76

Current Ratio	6.76
Quick Ratio	6.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.26
Interest Coverage	-5.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.87%
Return on Invested Capital (ROIC)	-44.93%
Return on Capital Employed (ROCE)	-49.97%
Revenue Per Employee	146,598
Profits Per Employee	-1.04M
Employee Count	498
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.02
Average Volume (20 Days)	3

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.43

Income Statement

In the last 12 months, Cytokinetics had revenue of EUR 73.01 million and -516.27 million in losses. Loss per share was -4.36.

Revenue	73.01M
Gross Profit	-259.62M
Operating Income	-465.75M
Pretax Income	-516.27M
Net Income	-516.27M
EBITDA	-457.77M
EBIT	-465.75M
Loss Per Share	-4.36

Full Income Statement

Balance Sheet

The company has 730.70 million in cash and 844.48 million in debt, giving a net cash position of -113.78 million.

Cash & Cash Equivalents	730.70M
Total Debt	844.48M
Net Cash	-113.78M
Net Cash Per Share	n/a
Equity (Book Value)	-313.97M
Book Value Per Share	-2.63
Working Capital	643.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -363.52 million and capital expenditures -10.05 million, giving a free cash flow of -373.57 million.

Operating Cash Flow	-363.52M
Capital Expenditures	-10.05M
Free Cash Flow	-373.57M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-637.96%
Pretax Margin	-707.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cytokinetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.37%
Shareholder Yield	n/a
Earnings Yield	-13.07%
FCF Yield	-9.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cytokinetics has an Altman Z-Score of -1.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.99
Piotroski F-Score	3